Product sales
Search documents
nLight Shares Rise 14% on Q3 Earnings Beat, Revenues Up Y/Y
ZACKS· 2025-11-10 16:37
Core Insights - nLight (LASR) shares have increased by 14% following the release of better-than-expected third-quarter 2025 results on November 6 [1] - The company reported earnings per share (EPS) of 8 cents, compared to a loss of 8 cents in the same quarter last year, surpassing the Zacks Consensus Estimates of 2 cents per share [1][7] - Net revenues reached $66.74 million, reflecting an 18.9% year-over-year increase and exceeding the Zacks Consensus Estimate by 6.8% [1][7] Revenue Breakdown - Revenues from the Aerospace and Defense sector amounted to $45.55 million, accounting for 68.3% of total revenues, marking a 50.5% increase from the prior-year quarter [2] - Revenues from the Industrial sector were $9.58 million, representing 14.3% of total revenues, which is a decrease of 17.4% year-over-year [2] - Revenues from the Microfabrication sector totaled $11.61 million, making up 17.4% of total revenues, down 18.6% from the previous year [2] Financial Performance - Product sales were $47.61 million, contributing 71.3% to total revenues, an increase of 15.7% year-over-year [3] - Development sales reached $19.13 million, accounting for 28.7% of total revenues, up 27.6% from the prior-year quarter [3] - Gross margin improved to 31.1%, expanding by 870 basis points from the year-ago quarter [3] - Operating loss narrowed to $7.23 million, compared to a loss of $11.79 million in the same quarter last year [3] Balance Sheet Overview - As of September 30, 2025, cash, cash equivalents, and marketable securities totaled $115.79 million, an increase from $113.70 million as of June 30, 2025 [4] Future Guidance - For the fourth quarter of 2025, nLight expects revenues to be between $72 million and $78 million [5] - The company anticipates a gross margin between 27% and 32% [5] - Adjusted EBITDA is projected to be in the range of $6 million to $11 million [5] Market Position - nLight currently holds a Zacks Rank 2 (Buy) [6]
Kratos (KTOS) Reports Q3 Earnings: What Key Metrics Have to Say
ZACKS· 2025-11-05 00:01
Core Insights - Kratos (KTOS) reported $347.6 million in revenue for Q3 2025, a 26% year-over-year increase, with an EPS of $0.14 compared to $0.11 a year ago, exceeding both revenue and EPS estimates [1][4] Revenue Breakdown - Product sales reached $230.2 million, surpassing the average estimate of $191.59 million, reflecting a 33.8% year-over-year increase [4] - Unmanned Systems generated $87.2 million, exceeding the estimated $77.18 million, marking a 35.8% increase from the previous year [4] - Kratos Government Solutions reported $260.4 million, above the $248.03 million estimate, representing a 23% year-over-year growth [4] - Service revenues totaled $117.4 million, below the average estimate of $133.04 million, with a 13% increase year-over-year [4] Profitability Metrics - Gross profit from service revenues was $26.2 million, lower than the $33.11 million estimate [4] - Gross profit from product sales was $50.9 million, exceeding the $44.6 million estimate [4] - Operating income for Kratos Government Solutions was $13.7 million, below the $16.75 million estimate [4] Stock Performance - Kratos shares have returned -9.1% over the past month, contrasting with the Zacks S&P 500 composite's +2.1% change, but the stock holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ZACKS· 2025-08-08 15:01
Core Insights - SurModics reported revenue of $29.57 million for the quarter ended June 2025, a decrease of 2.6% year-over-year, but exceeded the Zacks Consensus Estimate by 4.29% [1] - The company achieved an EPS of $0.06, a significant improvement from -$0.27 in the same quarter last year, resulting in an EPS surprise of 128.57% compared to the consensus estimate of -$0.21 [1] Revenue Breakdown - Product sales amounted to $16.76 million, surpassing the average estimate of $15.69 million, but reflecting a year-over-year decline of 4.6% [4] - Revenue from research, development, and other sources was $3.15 million, exceeding the average estimate of $2.37 million, marking a year-over-year increase of 35.7% [4] - Royalties and license fees generated $9.66 million, slightly below the estimated $10.2 million, representing a year-over-year decrease of 7.7% [4] Stock Performance - SurModics shares have returned +12.9% over the past month, outperforming the Zacks S&P 500 composite's +1.9% change [3] - The stock currently holds a Zacks Rank 5 (Strong Sell), indicating potential underperformance relative to the broader market in the near term [3]
Stay Ahead of the Game With European Wax Center (EWCZ) Q2 Earnings: Wall Street's Insights on Key Metrics
ZACKS· 2025-08-08 14:15
Group 1 - European Wax Center, Inc. (EWCZ) is expected to report quarterly earnings of $0.19 per share, a 26.7% increase year-over-year, while revenues are forecasted at $56.93 million, reflecting a 4.9% decrease compared to the same period last year [1] - The consensus EPS estimate has remained unchanged over the last 30 days, indicating that analysts have collectively reassessed their initial estimates during this period [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock price performance [3] Group 2 - Analysts project 'Revenue- Marketing fees' to reach $7.79 million, a decrease of 4.3% from the prior-year quarter [5] - 'Revenue- Royalty fees' is estimated at $14.02 million, suggesting a 3.1% year-over-year decline [5] - 'Revenue- Product sales' is expected to be $31.29 million, indicating a 7.8% decrease year-over-year [5] - 'Revenue- Other revenue' is projected at $3.22 million, reflecting a 3.7% decline from the previous year [6] - The consensus for 'Ending center count' is 1,054, down from 1,059 in the same quarter last year [6] Group 3 - Over the past month, European Wax Center shares have declined by 23.5%, while the Zacks S&P 500 composite has increased by 1.9% [7] - EWCZ holds a Zacks Rank 3 (Hold), suggesting that its performance is likely to align with the overall market in the near future [7]
Where Food es From(WFCF) - 2025 Q2 - Earnings Call Presentation
2025-08-07 16:00
Financial Performance - Second Quarter 2025 - Total revenue increased to $66 million from $64 million, a 3% increase year-over-year[2,4] - Verification and certification revenue increased to $533 million from $525 million[2,6] - Product sales increased to $964,000 from $819,000[2,6] - Net income increased to $562,000, or $011 per diluted share, from $489,000, or $009 per diluted share, a 15% increase[2,3,7] Financial Performance - Six Months 2025 - Total revenue decreased to $118 million from $120 million[2,8] - Verification and certification services was $95 million vs $97 million[2,12] - Product revenue was $17 million vs $16 million[2,12] - Net income decreased to $593,000, or $011 per diluted share, from $667,000, or $012 per diluted share[2,9] Strategic Actions - The company sold its 10% interest in Progressive Beef for $18 million in cash and the return of 12,585 shares of WFCF common stock[1,6] - The company bought back 24,481 shares in the second quarter and 55,826 shares in the first six months of 2025[2,6,7,10]
SurModics (SRDX) Reports Q2 Earnings: What Key Metrics Have to Say
ZACKS· 2025-04-30 15:00
Core Insights - SurModics reported a revenue of $28.09 million for the quarter ended March 2025, reflecting a decline of 12.1% year-over-year and an earnings per share (EPS) of -$0.13, compared to $0.07 in the same quarter last year [1] - The revenue fell short of the Zacks Consensus Estimate of $30.77 million by 8.73%, and the EPS was significantly below the consensus estimate of -$0.06, resulting in an EPS surprise of -116.67% [1] Revenue Breakdown - Product sales amounted to $14.99 million, which is a decrease of 17.2% year-over-year and below the average estimate of $17.46 million from two analysts [4] - Revenue from research, development, and other sources was $3.19 million, exceeding the two-analyst average estimate of $2.41 million, marking a year-over-year increase of 30.1% [4] - Royalties and license fees generated $9.91 million, slightly below the average estimate of $10.37 million from two analysts, representing a year-over-year decline of 13.2% [4] Stock Performance - Over the past month, shares of SurModics have returned +0.1%, contrasting with a -0.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]